ACR Convergence 2026 Archives - ACR Meeting Abstracts

Abstract Number: 0957

B Cells in Takayasu Arteritis Upregulate Genes Involved in RNA Splicing, Protein Synthesis, and BCR Signaling Compared to Healthy Individuals
Abstract Number: 2940

B-cell Counts and Inflammation Markers Predicting Prevalence and Severity of Cytokine-Release Syndrome in CAR T-Cell Therapy of Patients with Autoimmune Disease
Abstract Number: 0478

Baricitinib in rheumatoid arthritis-associated interstitial lung disease: a national multicenter study of 84 patients
Abstract Number: 1400

Baricitinib vs TNF Inhibitors in Rheumatoid Arthritis at Increased VTE Risk: Long-Term Safety, Exploratory Efficacy, and the Impact of COVID-19 on Serious Infections
Abstract Number: 1493

Barriers and Facilitators of Medication Adherence in Childhood-Onset Systemic Lupus Erythematosus: A Qualitative Study
Abstract Number: 1529

Barriers and Facilitators to Vaccinations among COVID-19 Unvaccinated Patients with Autoimmune Rheumatic Diseases: A Qualitative Study
Abstract Number: 1530

Barriers to Care in Pediatric Uveitis Patients and Families: A Mixed-Methods Study
Abstract Number: 2486

Barriers to Enrollment in Clinical Trials of patients with childhood onset Systemic Lupus Erythematosus – Perspectives from a randomized, multi-center clinical trial in Pediatric Lupus Nephritis
Abstract Number: 0194

Baseline ‘aggregate index of systemic inflammation’ reflects current high activity and predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis
Abstract Number: 0004

Baseline and early longitudinal serum biomarkers in Polymyalgia Rheumatica: kinetics and associations with clinical course
Abstract Number: 0080

Baseline cfDNA Active Chromatin Profiles Reflect Synovial Pathotype-Associated Biology Distinguishing Response to Targeted Treatments in Rheumatoid Arthritis
Abstract Number: 0348

Baseline Characteristics and 12-Month Effectiveness of Guselkumab and IL-17 Inhibitors Among Participants with Oligoarticular Psoriatic Arthritis in the Global PsABIOnd Study
Abstract Number: 2607

Baseline Characteristics and Outcomes of Patients with Fibrosing Mediastinitis Treated with Rituximab: A Single‑Center Retrospective Cohort
Abstract Number: 0227

Baseline Characteristics and Preliminary Data from Existing Patient-Reported Outcome Measures- Data from the CRISTAL Multicenter Cohort of Patients with Limited Cutaneous or Sine Scleroderma Systemic Sclerosis
Abstract Number: 2320

Baseline Characteristics and Treatment Patterns in the Kuwait National Axial Spondyloarthritis Registry: First Report from a National Multicenter Cohort
Abstract Number: 1609

Baseline Characteristics of Patients in a Phase 3, Randomized, Placebo-Controlled Trial of Admilparant (BMS-986278), an Oral Lysophosphatidic Acid Receptor 1 Antagonist, in Progressive Pulmonary Fibrosis
Abstract Number: 2168

Baseline Characteristics of the APLAR Systemic Sclerosis Incident Cohort (APSSIC)
Abstract Number: 1831

Baseline Characteristics of the Prospective, Multicentre, International Cohort for the New Classification Criteria of Juvenile Idiopathic Arthritides
Abstract Number: 0557

Baseline Clinical, Sonographic and Immunologic Features Associated with Clinical Inactive Disease at 6-months in Children with Non-Systemic Juvenile Idiopathic Arthritis
Abstract Number: 0674

Baseline disease characteristics in IgG4-related disease study participants with and without flare: post hoc analysis of a phase 2a study of rilzabrutinib
Abstract Number: 1039

Baseline Epiproteomics Reveals Proteoform-Level Separation Between TNF Inhibitor Responders and Non-Responders in Rheumatoid Arthritis
Abstract Number: 2285

Baseline Erosion Burden Does Not Impact Improvement of Clinical Response to Secukinumab in Patients with Psoriatic Arthritis
Abstract Number: 1982

Baseline Immunometabolic Signatures Predict Future Disease Worsening in Clinically Stable Systemic Lupus Erythematosus
Abstract Number: 2822

Baseline Nociplastic Pain Features are Associated with Worse Longitudinal Physical Function in Chronic Low Back Pain
Abstract Number: 1963

Baseline Peripheral Blood Transcriptomic Signatures Are Associated with ILD Progression in Diffuse Cutaneous Systemic Sclerosis
Abstract Number: 0349

Baseline Predictors of ACR Response to Tildrakizumab in Patients with Psoriatic Arthritis: An Elastic Net Analysis of Pooled Phase 3 Trials
Abstract Number: 1688

Baseline Quantitative Computed Tomography Scores Predict Progression in Patients with Progressive Pulmonary Fibrosis
Abstract Number: 2031

Baseline secretory component-containing ACPA levels in anti-CCP antibody positive individuals are predictive of future RA development but are not associated with periodontal disease status
Abstract Number: 0195

Baseline serum angiopoietin-like 4 is associated with subsequent end-stage kidney disease in patients with MPA or GPA
Abstract Number: 1052

Baseline sputum cytokines associated with future development of clinical RA in an at-risk cohort
Abstract Number: 2487

Baseline STIR-MRI Fatty Infiltration Predicts Long-Term Outcomes in Juvenile Dermatomyositis
Abstract Number: 1689

Baseline Synovitis in Knee Osteoarthritis is Associated With 2 Year 3D Bone Shape (B-score) Progression but not Cartilage Thickness Change
Abstract Number: 0620

Bayesian Borrowing for Fracture Risk Factors in Female Romosozumab New Users Across Racial and Ethnic Subgroups
Abstract Number: 2154

BCMAxCD3 bispecific antibody therapy with teclistamab induces B- and plasma cell depletion and clinical efficacy in treatment of refractory systemic sclerosis – a case series
Abstract Number: 1211

BE-EARLY: Interim Week 26 Analysis of a Phase 4, Prospective, Open-Label Study Evaluating Belimumab in Early SLE (≤2 Years Since Diagnosis)
Abstract Number: 0591

Beliefs and Attitudes about Glucocorticoids Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Cross-sectional Study
Abstract Number: 0860

Belimumab for Refractory and Non-criteria Manifestations of Primary Antiphospholipid Syndrome: Results from the Prospective Phase II BLAST Trial
Abstract Number: 1040

Berberine alleviates rheumatoid arthritis by selectively targeting mitochondrial complex I to restore Th17/Treg immune homeostasis
Abstract Number: 2488

Best Practices for Medication Tapering and Discontinuation in Systemic Juvenile Idiopathic Arthritis: A Systematic Review
Abstract Number: 0648

Beyond Anti-MDA5 Dermatomyositis: Clinical Spectrum, ILD Burden, and Mortality Among 2,489 Anti-MDA5-Positive Adults
Abstract Number: 1560

Beyond Bone Mineral Density: Bone Microarchitecture In Systemic Lupus Erythematosus Assessed By Trabecular Bone Score (Tbs)
Abstract Number: 2608

Beyond Chondritis : Unveiling Joint Involvements in VEXAS patients From a Belgo-Swiss Cohort
Abstract Number: 0621

Beyond Closing the Treatment Gap: Clinical and System-Level Determinants of Osteoporosis Treatment Initiation After Fragility Fracture in an Interhospital Fracture Liaison Service
Abstract Number: 1303

Beyond Disease Activity: A Telemedicine-Based Holistic Care Intervention for Patients with Psoriatic Arthritis
Abstract Number: 2968

Beyond Geography: Social Determinants of Health Drive Disparities in Access to Health Education in Adults with Rheumatologic Conditions
Abstract Number: 1924

Beyond Glycemic Control: GLP-1 Receptor Agonists Reduce Joint Replacement Rates and In-Hospital Mortality in Osteoarthritis and Rheumatoid Arthritis – A National Inpatient Sample Study, 2016-2023
Abstract Number: 0381

Beyond Inflammation: Patient-Level Factors Associated with Persistent Fatigue in Psoriatic Arthritis
Abstract Number: 1561

Beyond Inflammation: Serum 14-3-3η and Low Bone Mineral Density in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
Abstract Number: 2702

Beyond Metabolic Syndrome: Machine Learning-Derived Phenotypes and Cardiovascular Outcomes in Premature Acute Coronary Syndrome (2016-2020)
Abstract Number: 0104

Beyond Myositis Specific Autoantibodies (MSAs): Autoantibody Profiling Reveals Broad IgG Autoreactivity and Sub-Phenotypic Structure in Juvenile Dermatomyositis and Traditional MSA Groups
Abstract Number: 0294

Beyond Respiratory Symptoms: Overlapping Thoracic Computed Tomography Phenotypes in Systemic Lupus Erythematosus
Abstract Number: 1431

Beyond RF and Anti-CCP: RA Reflex Testing of Anti-CarP, Anti-MCV, Anti-Sa, and Anti-CEP Yields 19.4% Incremental Diagnostic Benefit
Abstract Number: 1717

Beyond Schooling: Level Of Knowledge About Osteoporosis In Patients With Autoimmune Diseases
Abstract Number: 2936

Beyond Seven Days: Ferritin Kinetics in Adult ICU Hemophagocytic Lymphohistiocytosis
Abstract Number: 1015

Beyond Susceptibility to Damage: Longitudinal Associations of Complement C4 Gene Copy Number in SLE
Abstract Number: 1481

Beyond the Checkbox: An Autoethnographic Exploration of Imposter Syndrome and the Development of Resilience Across Clinical Rotations
Abstract Number: 1797

Beyond the Diet: Barriers, Facilitators, and Acceptability of Dietary Behaviour Change in Patients with Psoriatic Arthritis Participating in the DIPSA Randomized Controlled Trial
Abstract Number: 2169

Beyond the esophagus: hyoid dysfunction is associated with dysphagia severity from early Systemic Sclerosis stages
Abstract Number: 1253

Beyond the Glomerulus: Tubulointerstitial Findings Predict Dialysis Progression and Reveal Racial Differences in Lupus Nephritis
Abstract Number: 2418

Beyond the Joints: National Trends in Cardiovascular Mortality in Rheumatoid Arthritis
Abstract Number: 0764

Beyond the Joints: Nationwide Trends in Ischemic Heart Disease Mortality Among Older Adults with Rheumatoid Arthritis
Abstract Number: 0558

Beyond the Joints: Systemic Juvenile Idiopathic Arthritis Without Arthritis Defines a High-Risk Hyperinflammatory Phenotype with Increased Macrophage Activation Syndrome and Organ Involvement
Abstract Number: 0861

Beyond the Lecture: Standardizing Antiphospholipid Syndrome Evaluation Through EMR-Based Clinical Decision Support
Abstract Number: 2687

Beyond The Surface: Utility Of Infrared Thermography In Distinguishing Activity From Damage In Localised Scleroderma
Abstract Number: 2688

Beyond UIP pattern: Predicting Immunomodulatory Response in Rheumatoid Arthritis Interstitial Lung Disease
Abstract Number: 1254

BILAG 2004 Low Disease Activity States as Alternative Endpoints to SRI 4 and BICLA in SLE
Abstract Number: 2550

Bilateral Hip DXA Identifies Patients With Isolated Right-Hip Osteoporosis and Higher Fragility Fracture Prevalence: A Large Cross-Sectional Study
Abstract Number: 1843

Bile Acid-TGR5 Signaling Attenuates Hyperuricemia by Suppressing Hepatic Xanthine Oxidase
Abstract Number: 1304

Bimekizumab and Glucagon-Like Peptide-1 Receptor Agonist Concomitant Use in Patients with Psoriatic Arthritis and Axial Spondyloarthritis: A Cross-Sectional Analysis of US Claims Data
Abstract Number: 0350

Bimekizumab Cardiovascular-Related Safety and Impact on Cardiometabolic Markers in Patients with Axial Spondyloarthritis and Psoriatic Arthritis with High Levels of Systemic Inflammation: 3-Year Results from Phase 3 Trials
Abstract Number: 1305

Bimekizumab Demonstrated Consistent Efficacy and Safety in Patients with Active Psoriatic Arthritis Classed as Obese or Overweight: 3-Year Pooled, Post Hoc Results from Two Phase 3 Studies
Abstract Number: 1306

Bimekizumab Demonstrated Maintenance of Clinical Efficacy Responses to 3 Years in Patients with Active Psoriatic Arthritis from Two Phase 3 Studies
Abstract Number: 1307

Bimekizumab Demonstrated Sustained Efficacy Over Three Years in Patients with Axial Spondyloarthritis Regardless of Baseline MRI/CRP Status: Results from Two Phase 3 Trials and their Open-Label Extension
Abstract Number: 2804

Bimekizumab Efficacy & Safety Versus Risankizumab in Patients with Active Psoriatic Arthritis: 24-Week Results from a Head-To-Head, Multicenter, Randomized, Phase 3b Study
Abstract Number: 0351

Bimekizumab Experience in Spondyloarthritis and Psoriatic Arthritis in Routine Clinical Practice in Spain: The BIMPACT Study
Abstract Number: 2286

Bimekizumab for the treatment of Psoriatic Arthritis (PsA): a cost-per-responder (CPR) analysis
Abstract Number: 1482

BINGO Bash: A Multi-Center Gamification Intervention to Improve Musculoskeletal Education in Internal Medicine Residency
Abstract Number: 0479

Bioelectrical Impedance versus Dual Energy X-ray Absorptiometry for Sarcopenic Obesity in Rheumatoid Arthritis Patients
Abstract Number: 0352

Biologic persistence and treatment sequencing in Axial Spondyloarthritis from a real-world cohort study
Abstract Number: 0295

Biologic Treatment Patterns in Abdominal and Pleuropericardial Serositis in Systemic Lupus Erythematosus: A Scoping Review
Abstract Number: 0978

Biological response in dermal fibroblasts predicts skin clinical response: Lessons from the MT-7117 Phase 2 Systemic Sclerosis clinical trial
Abstract Number: 2943

Biomarker-Driven Insights From the Phase 2a AFFINITY Study Evaluating Guselkumab + Golimumab Combination Therapy Versus Guselkumab Monotherapy in Psoriatic Arthritis
Abstract Number: 1368

Biomarker-Driven Insights to Clinical Response with Nipocalimab: A Phase 2 Randomized Trial for Sjögren’s Disease
Abstract Number: 2419

Biomarkers for Atherosclerotic Cardiovascular Events in Rheumatoid Arthritis: Towards Validation of a Biomarker-Enhanced Risk Model
Abstract Number: 2097

Biopsy-Positive Giant Cell Arteritis Is Associated With Increased CTA Utilization for Extracranial Vascular Assessment
Abstract Number: 1950

Bispecific CD20xCD40 Antibodies Achieve Multi-Lineage Modulation of Humoral and Cellular Immunity
Abstract Number: 1255

Black Carbon In Air Pollution Is Associated With Lupus Nephritis Onset: A Population Based Open-Cohort Study In The United States
Abstract Number: 0040

Blockade of Mechanistic Target of Rapamycin Complexes 1 and 2 across Anti-Inflammatory Tregs and Pro-Inflammatory CD8+ TEMRA, CD4+ Tfh, and Long-Lived Plasma Cells Underlies Therapeutic Action of N-acetylcysteine in Patients with Active Systemic Lupus Erythematosus
Abstract Number: 1646

Blood transcriptome and serum protein biomarkers associated with tophaceous gout
Abstract Number: 1432

Blood-Derived Inflammatory Indices in Individuals at Risk of Developing Rheumatoid Arthritis
Abstract Number: 2420

Body Adiposity Index Is Associated with Moderate-to-High Disease Activity in Rheumatoid Arthritis
Abstract Number: 0622

Bone-Sparing Effects of Novel Glucocorticoid Compounds: A Systematic Review of In Vivo Preclinical Evidence
Abstract Number: 1335

Brain Activation during a Visual Task Reveals Neural Correlates of Chronic Pain in Axial Spondyloarthritis
Abstract Number: 1798

Brain Fog in Systemic Sclerosis: Baseline Cognitive Function and Patient-Reported Outcomes from an Online Cognitive Rehabilitation Program
Abstract Number: 2738

Breaking the Stereotype: Distinct Clinical and Comorbidity Profiles of Female Patients With Gout
Abstract Number: 1584

Brepocitinib Achieves Rapid and Sustained Control of Cutaneous Disease Activity, Itch, and Skin-Related Quality of Life in Dermatomyositis: Results From the Phase 3 VALOR Trial
Abstract Number: 1585

Brepocitinib Demonstrates Consistent Benefit on Combined Measures of Clinical Response and Sustained Corticosteroid Tapering in Dermatomyositis Patients at One Year
Abstract Number: 1586

Brepocitinib Demonstrates Consistent Clinical Responses Along With Reduced Oral Corticosteroid Use in Dermatomyositis Patients With Interstitial Lung Disease: Results From the Phase 3 VALOR Trial
Abstract Number: 1587

Brepocitinib Improves Patient-Reported Physical Disability, Pain, and Fatigue in Dermatomyositis Patients at One Year
Abstract Number: 0532

Bridging Gaps Through Multidisciplinary Care for High-Risk Pregnancies in Autoimmune Rheumatic Disease
Abstract Number: 1336

Bridging the Gut-Joint Axis: Diagnostic and Prognostic Performance of Fecal Calprotectin in Axial Spondyloarthritis
Abstract Number: 2948

Bridging the Rheumatology Access Gap: Inpatient Transfer Patterns and Virtual Inpatient Consultation Outcomes at a Tertiary Referral Center
Abstract Number: 2772

Building MSK POCUS Competency in Internal Medicine Residency: A 15-Week Longitudinal Outpatient Teaching Curriculum
Abstract Number: 1483

Building the Next Generation: A Global Snapshot of Pediatric Rheumatology Training Programs
Abstract Number: 2421

Burden of Multimorbidity and Polypharmacy in Rheumatoid Arthritis: Evidence from a Nationally Representative U.S. Sample
Abstract Number: 2233

Burden of Renal Failure in Systemic Lupus Erythematosus: A US Mortality Analysis (1999-2024)
Abstract Number: 2665

Burden of Severe COVID-19 and Vaccine Effectiveness in Patients with Rheumatic Diseases: A Population-Based Cohort Study Across Pandemic Periods in Quebec